- Home
- NLSP vs FTFT Comparison
NLSP vs FTFT Comparison
Compare NLSP & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- FTFT
- Stock Information
- Founded
- NLSP 2015
- FTFT N/A
- Country
- NLSP Switzerland
- FTFT United States
- Employees
- NLSP N/A
- FTFT N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- FTFT Business Services
- Sector
- NLSP Health Care
- FTFT Consumer Discretionary
- Exchange
- NLSP Nasdaq
- FTFT Nasdaq
- Market Cap
- NLSP 243.8M
- FTFT N/A
- IPO Year
- NLSP 2021
- FTFT N/A
- Fundamental
- Price
- NLSP $4.96
- FTFT $0.34
- Analyst Decision
- NLSP
- FTFT
- Analyst Count
- NLSP 0
- FTFT 0
- Target Price
- NLSP N/A
- FTFT N/A
- AVG Volume (30 Days)
- NLSP 34.6K
- FTFT 144.5K
- Earning Date
- NLSP 11-01-2024
- FTFT 11-18-2024
- Dividend Yield
- NLSP N/A
- FTFT N/A
- EPS Growth
- NLSP N/A
- FTFT N/A
- EPS
- NLSP N/A
- FTFT N/A
- Revenue
- NLSP N/A
- FTFT $37,105,708.00
- Revenue This Year
- NLSP N/A
- FTFT N/A
- Revenue Next Year
- NLSP N/A
- FTFT N/A
- P/E Ratio
- NLSP N/A
- FTFT N/A
- Revenue Growth
- NLSP N/A
- FTFT 84.77
- 52 Week Low
- NLSP $4.08
- FTFT $0.29
- 52 Week High
- NLSP $29.68
- FTFT $2.60
- Technical
- Relative Strength Index (RSI)
- NLSP 46.37
- FTFT 51.19
- Support Level
- NLSP $4.52
- FTFT $0.30
- Resistance Level
- NLSP $5.64
- FTFT $0.36
- Average True Range (ATR)
- NLSP 0.48
- FTFT 0.03
- MACD
- NLSP 0.07
- FTFT 0.00
- Stochastic Oscillator
- NLSP 55.44
- FTFT 58.43
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.